Page 1 | Search Results | Hematology, ASH Education Program

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Hemophilia and inhibitors: current treatment options and potential new therapeutic approaches

Shannon L. Meeks, Glaivy Batsuli

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 657–662.

https://doi.org/10.1182/asheducation-2016.1.657

Published: 2016

Journal Articles

Treatment of rare factor deficiencies in 2016

Flora Peyvandi, Marzia Menegatti

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 663–669.

https://doi.org/10.1182/asheducation-2016.1.663

Published: 2016

Journal Articles

Coagulopathy in liver disease: a balancing act

Jody L. Kujovich

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 243–249.

https://doi.org/10.1182/asheducation-2015.1.243

Published: 2015

Journal Articles

Bleeding complications of targeted oral anticoagulants: what is the risk?

Michael Levine, Joshua N. Goldstein

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 504–509.

https://doi.org/10.1182/asheducation-2014.1.504

Published: 2014

Journal Articles

Reversing targeted oral anticoagulants

Maureane Hoffman, Dougald M. Monroe

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 518–523.

https://doi.org/10.1182/asheducation-2014.1.518

Published: 2014

Journal Articles

Future prospects for contact factors as therapeutic targets

David Gailani

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 52–59.

https://doi.org/10.1182/asheducation-2014.1.52

Published: 2014

Journal Articles

The old and new: PCCs, VIIa, and long-lasting clotting factors for hemophilia and other bleeding disorders

Margaret V. Ragni

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 44–51.

https://doi.org/10.1182/asheducation-2013.1.44

Published: 2013

Journal Articles

Pros and cons of new oral anticoagulants

Kenneth A. Bauer

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 464–470.

https://doi.org/10.1182/asheducation-2013.1.464

Published: 2013

Journal Articles

Current consideration and management of disseminated intravascular coagulation

Cheng Hock Toh, Yasir Alhamdi

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 286–291.

https://doi.org/10.1182/asheducation-2013.1.286

Published: 2013

Journal Articles

Hemostatic defects in liver and renal dysfunction

Pier Mannuccio Mannucci, Armando Tripodi

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 168–173.

https://doi.org/10.1182/asheducation.V2012.1.168.3798232

Published: 2012

Journal Articles

Thrombotic disease in the myeloproliferative neoplasms

Anna Falanga, Marina Marchetti

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 571–581.

https://doi.org/10.1182/asheducation.V2012.1.571.3798557

Published: 2012

Journal Articles

Pathogenesis of thrombosis

Bruce Furie

Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 255–258.

https://doi.org/10.1182/asheducation-2009.1.255

Published: 2009

Journal Articles

Hypercoagulability in Sickle Cell Disease: New Approaches to an Old Problem

Kenneth I. Ataga, Nigel S. Key

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 91–96.

https://doi.org/10.1182/asheducation-2007.1.91

Published: 2007

Journal Articles

Perioperative Evaluation of Bleeding Diathesis

Lawrence L.K. Leung

Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 457–461.

https://doi.org/10.1182/asheducation-2006.1.457

Published: 2006

Journal Articles

Think of HIT

Theodore E. Warkentin

Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 408–414.

https://doi.org/10.1182/asheducation-2006.1.408

Published: 2006

Journal Articles

Consultations on Patients with Venous or Arterial Diseases

Barbara M. Alving, Charles W. Francis, William R. Hiatt, Mark R. Jackson

Hematology Am Soc Hematol Educ Program (2003) 2003 (1): 540–558.

https://doi.org/10.1182/asheducation-2003.1.540

Published: 2003

Journal Articles

Platelet-Endothelial Interactions: Sepsis, HIT, and Antiphospholipid Syndrome

Theodore E. Warkentin, William C. Aird, Jacob H. Rand

Hematology Am Soc Hematol Educ Program (2003) 2003 (1): 497–519.

https://doi.org/10.1182/asheducation-2003.1.497

Published: 2003

Journal Articles

Advances in Therapy and the Management of Antithrombotic Drugs for Venous Thromboembolism

Jack E. Ansell, Jeffrey I. Weitz, Anthony J. Comerota

Hematology Am Soc Hematol Educ Program (2000) 2000 (1): 266–284.

https://doi.org/10.1182/asheducation.V2000.1.266.266

Published: 2000

NARROW

Hemophilia and inhibitors: current treatment options and potential new therapeutic approaches

Treatment of rare factor deficiencies in 2016

Coagulopathy in liver disease: a balancing act

Bleeding complications of targeted oral anticoagulants: what is the risk?

Reversing targeted oral anticoagulants

Future prospects for contact factors as therapeutic targets

The old and new: PCCs, VIIa, and long-lasting clotting factors for hemophilia and other bleeding disorders

Pros and cons of new oral anticoagulants

Current consideration and management of disseminated intravascular coagulation

Hemostatic defects in liver and renal dysfunction

Thrombotic disease in the myeloproliferative neoplasms

Pathogenesis of thrombosis

Hypercoagulability in Sickle Cell Disease: New Approaches to an Old Problem

Perioperative Evaluation of Bleeding Diathesis

Think of HIT

Consultations on Patients with Venous or Arterial Diseases

Platelet-Endothelial Interactions: Sepsis, HIT, and Antiphospholipid Syndrome

Advances in Therapy and the Management of Antithrombotic Drugs for Venous Thromboembolism

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only